학술논문

NO ADVANTAGES IN THE ADDITION OF IFOSFAMIDE AND VP-16 TO THE STANDARD 4-DRUG REGIMEN IN THE MAINTENANCE PHASE OF NEOADJUVANT CHEMOTHERAPY OF EWINGS-SARCOMA OF BONE - RESULTS OF 2 SEQUENTIAL STUDIES
Document Type
Journal
Source
JOURNAL OF CHEMOTHERAPY; AUG 1993, 5 4, p247-p257, 11p.
Subject
Language
English
ISSN
1120009X